|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Licensing and collaboration revenue | |||||
| Supply of investigational products | |||||
| Total revenues | |||||
| Expenses | |||||
| Research and development expenses (including amounts with related parties of $47,071, $0, and $0, respectively) | |||||
| Administrative expenses (including amounts with related parties of $2,600, $239, and $0, respectively - Note 17) | |||||
| Impairment of goodwill | |||||
| Total Expenses | |||||
| Loss from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Other expenses, net | |||||
| Equity in loss of affiliates | |||||
| Loss from continuing operations before income tax expense | |||||
| Income tax expense | |||||
| Loss from continuing operations | |||||
| Discontinued operations: | |||||
| Loss from operations of discontinued operations | |||||
| Gain on sale of discontinued operations | |||||
| Gain (loss) from discontinued operations | |||||
| Net loss | |||||
| Unrealized gain (loss) on available-for-sale debt securities, net of tax | |||||
| Reclassification of accumulated gains on available-for-sale debt securities to earnings | |||||
| Foreign currency translation adjustments, net of tax | |||||
| Total other comprehensive loss | |||||
| Comprehensive loss attributable to redeemable noncontrolling interests | |||||
| Comprehensive loss attributable to NovaBridge | |||||
| Weighted-average number of ordinary shares used in calculating net loss per share - basic | |||||
| Weighted-average number of ordinary shares used in calculating net loss per share - diluted | |||||
| Net loss per share from continuing operations attributable to NovaBridge - basic | |||||
| ADS | |||||
| Total net loss per share from continuing operations attributable to NovaBridge - basic | |||||
| Net loss per share from continuing operations attributable to NovaBridge - diluted | |||||
| ADS | |||||
| Total net loss per share from continuing operations attributable to NovaBridge - diluted | |||||
| Net gain (loss) per share from discontinued operations - basic | |||||
| ADS | |||||
| Total net gain (loss) per share from discontinued operations - basic | |||||
| Net gain (loss) per share from discontinued operations - diluted | |||||
| ADS | |||||
| Total net gain (loss) per share from discontinued operations - diluted | |||||
| Net loss per share attributable to NovaBridge - basic | |||||
| ADS | |||||
| Total net loss per share attributable to NovaBridge - basic | |||||
| Net loss per share attributable to NovaBridge- diluted | |||||
| ADS | |||||
| Total net loss per share attributable to NovaBridge- diluted | |||||
| Net loss attributable to redeemable noncontrolling interests | |||||
| Net loss attributable to NovaBridge | |||||
| Net loss attributable to ordinary shareholders | |||||
Loading...